市場調査レポート

商品コード

日本の再生医療市場 2025～2029年

Regenerative Medicine Market in Japan 2025-2029

出版日: 2025年02月26日
発行: TechNavio
ページ情報: 英文 167 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 360,150円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 576,240円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

日本の再生医療市場は2024～2029年に46億60万米ドル、予測期間中のCAGRは21.2％で成長すると予測されます。

当レポートでは、日本の再生医療市場について、市場規模・予測、動向、成長促進要因、約25のベンダーを網羅したベンダー分析など、包括的な分析を掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、幹細胞療法の採用増加、慢性疾患の有病率の上昇、高齢者人口の増加によって牽引されています。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データを掲載しています。

市場範囲
基準年	2025年
終了年	2029年
予測期間	2025～2029年
成長モメンタム	加速
前年比2025年	17.3%
CAGR	21.2%
増分額	46億60万米ドル

本調査では、今後数年間における日本の再生医療市場の成長を牽引する主な要因の一つとして、臨床試験の増加を挙げています。また、企業間のM&Aや人工多能性幹細胞の開発が活発化していることも、市場の大きな需要につながると思われます。

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
Astellas Pharma Inc.
Becton Dickinson and Co.
CellSeed Inc.
Cyfuse Biomedical K.K.
F. Hoffmann La Roche Ltd.
FUJIFILM Holdings Corp.
iHeart Japan Corp.
JCR Pharmaceticals Co. Ltd.
Nikon Corp.
ROHTO Pharmaceutical Co. Ltd.
Sumitomo Pharma Co. Ltd.
Takara Bio Inc.
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.
Yokogawa Electric Corp.

第15章付録

Product Code: IRTNTR76343

The regenerative medicine market in Japan is forecasted to grow by USD 4600.6 million during 2024-2029, accelerating at a CAGR of 21.2% during the forecast period. The report on the regenerative medicine market in Japan provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of STEM cell therapy, rising prevalence of chronic diseases, and increasing aging population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	17.3%
CAGR	21.2%
Incremental Value	$4600.6 mn

Technavio's regenerative medicine market in Japan is segmented as below:

By Application

Oncology
Musculoskeletal
Dermatology
Others

By Technology

Cell and tissue-based
Gene therapy

By End-user

Hospitals and clinics
Speciality centers
Government and research institutes

By Geographical Landscape

APAC

This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicine market in Japan growth during the next few years. Also, growing mergers and acquisitions among companies and development of induced pluripotent STEM cells will lead to sizable demand in the market.

The report on the regenerative medicine market in Japan covers the following areas:

Regenerative Medicine Market in Japan sizing
Regenerative Medicine Market in Japan forecast
Regenerative Medicine Market in Japan industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicine market in Japan vendors that include Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp.. Also, the regenerative medicine market in Japan analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan: Year-over-year growth 2024-2029 (%)
- Data Table on Japan: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Regenerative Medicine Market in Japan 2019 - 2023
- Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Regenerative Medicine Market in Japan

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
8.4 Musculoskeletal - Market size and forecast 2024-2029
- Chart on Musculoskeletal - Market size and forecast 2024-2029 ($ million)
- Data Table on Musculoskeletal - Market size and forecast 2024-2029 ($ million)
- Chart on Musculoskeletal - Year-over-year growth 2024-2029 (%)
- Data Table on Musculoskeletal - Year-over-year growth 2024-2029 (%)
8.5 Dermatology - Market size and forecast 2024-2029
- Chart on Dermatology - Market size and forecast 2024-2029 ($ million)
- Data Table on Dermatology - Market size and forecast 2024-2029 ($ million)
- Chart on Dermatology - Year-over-year growth 2024-2029 (%)
- Data Table on Dermatology - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Technology

9.1 Market segments
- Chart on Technology - Market share 2024-2029 (%)
- Data Table on Technology - Market share 2024-2029 (%)
9.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
9.3 Cell and tissue-based - Market size and forecast 2024-2029
- Chart on Cell and tissue-based - Market size and forecast 2024-2029 ($ million)
- Data Table on Cell and tissue-based - Market size and forecast 2024-2029 ($ million)
- Chart on Cell and tissue-based - Year-over-year growth 2024-2029 (%)
- Data Table on Cell and tissue-based - Year-over-year growth 2024-2029 (%)
9.4 Gene therapy - Market size and forecast 2024-2029
- Chart on Gene therapy - Market size and forecast 2024-2029 ($ million)
- Data Table on Gene therapy - Market size and forecast 2024-2029 ($ million)
- Chart on Gene therapy - Year-over-year growth 2024-2029 (%)
- Data Table on Gene therapy - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Technology
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)

10 Market Segmentation by End-user

10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
10.3 Hospitals and clinics - Market size and forecast 2024-2029
- Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
10.4 Speciality centers - Market size and forecast 2024-2029
- Chart on Speciality centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Speciality centers - Market size and forecast 2024-2029 ($ million)
- Chart on Speciality centers - Year-over-year growth 2024-2029 (%)
- Data Table on Speciality centers - Year-over-year growth 2024-2029 (%)
10.5 Government and research institutes - Market size and forecast 2024-2029
- Chart on Government and research institutes - Market size and forecast 2024-2029 ($ million)
- Data Table on Government and research institutes - Market size and forecast 2024-2029 ($ million)
- Chart on Government and research institutes - Year-over-year growth 2024-2029 (%)
- Data Table on Government and research institutes - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
14.5 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
14.6 CellSeed Inc.
- CellSeed Inc. - Overview
- CellSeed Inc. - Product / Service
- CellSeed Inc. - Key offerings
- SWOT
14.7 Cyfuse Biomedical K.K.
- Cyfuse Biomedical K.K. - Overview
- Cyfuse Biomedical K.K. - Product / Service
- Cyfuse Biomedical K.K. - Key offerings
- SWOT
14.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
14.9 FUJIFILM Holdings Corp.
- FUJIFILM Holdings Corp. - Overview
- FUJIFILM Holdings Corp. - Business segments
- FUJIFILM Holdings Corp. - Key news
- FUJIFILM Holdings Corp. - Key offerings
- FUJIFILM Holdings Corp. - Segment focus
- SWOT
14.10 iHeart Japan Corp.
- iHeart Japan Corp. - Overview
- iHeart Japan Corp. - Product / Service
- iHeart Japan Corp. - Key offerings
- SWOT
14.11 JCR Pharmaceticals Co. Ltd.
- JCR Pharmaceticals Co. Ltd. - Overview
- JCR Pharmaceticals Co. Ltd. - Product / Service
- JCR Pharmaceticals Co. Ltd. - Key offerings
- SWOT
14.12 Nikon Corp.
- Nikon Corp. - Overview
- Nikon Corp. - Business segments
- Nikon Corp. - Key offerings
- Nikon Corp. - Segment focus
- SWOT
14.13 ROHTO Pharmaceutical Co. Ltd.
- ROHTO Pharmaceutical Co. Ltd. - Overview
- ROHTO Pharmaceutical Co. Ltd. - Business segments
- ROHTO Pharmaceutical Co. Ltd. - Key offerings
- ROHTO Pharmaceutical Co. Ltd. - Segment focus
- SWOT
14.14 Sumitomo Pharma Co. Ltd.
- Sumitomo Pharma Co. Ltd. - Overview
- Sumitomo Pharma Co. Ltd. - Business segments
- Sumitomo Pharma Co. Ltd. - Key offerings
- Sumitomo Pharma Co. Ltd. - Segment focus
- SWOT
14.15 Takara Bio Inc.
- Takara Bio Inc. - Overview
- Takara Bio Inc. - Product / Service
- Takara Bio Inc. - Key news
- Takara Bio Inc. - Key offerings
- SWOT
14.16 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
14.17 Terumo Corp.
- Terumo Corp. - Overview
- Terumo Corp. - Business segments
- Terumo Corp. - Key news
- Terumo Corp. - Key offerings
- Terumo Corp. - Segment focus
- SWOT
14.18 Yokogawa Electric Corp.
- Yokogawa Electric Corp. - Overview
- Yokogawa Electric Corp. - Business segments
- Yokogawa Electric Corp. - Key news
- Yokogawa Electric Corp. - Key offerings
- Yokogawa Electric Corp. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

日本の再生医療市場 2025～2029年

Regenerative Medicine Market in Japan 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio別分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：用途別

第9章市場セグメンテーション：技術別

第10章市場セグメンテーション：エンドユーザー別

第11章顧客情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Application

9 Market Segmentation by Technology

10 Market Segmentation by End-user

11 Customer Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

日本の再生医療市場 2025～2029年

Regenerative Medicine Market in Japan 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio別分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：用途別

第9章 市場セグメンテーション：技術別

第10章 市場セグメンテーション：エンドユーザー別

第11章 顧客情勢

第12章 促進要因・課題・機会・抑制要因

第13章 競合情勢

第14章 競合分析

第15章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Application

9 Market Segmentation by Technology

10 Market Segmentation by End-user

11 Customer Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：用途別

第9章市場セグメンテーション：技術別

第10章市場セグメンテーション：エンドユーザー別

第11章顧客情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録